SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Scott Weiner will join a panel discussion around perspectives on biotechnology transfer and investments at GTC’s Biotechnology Transfer & Commercialization Conference, October 24-26, 2012 in Philadelphia, PA.
News | 07. 31. 2012
Scott Weiner will join a panel discussion around perspectives on biotechnology transfer and investments at GTC’s Biotechnology Transfer & Commercialization Conference, October 24-26, 2012 in Philadelphia, PA.
